OTC · Medical - Devices

Nemaura Medical Inc. (NMRD) Stock

$0.00 OTC: NMRD Healthcare

Nemaura Medical Inc. is a medical technology company dedicated to inventing, developing, and bringing to market diagnostic medical devices.

Valuation

MetricValue
Price$0.00
Market Cap$4035
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.05
EPS (TTM)$-0.39
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE116.67%
ROA-81.19%
ROCE124.54%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-1.67
Current Ratio0.19

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$1.0M$0
Operating Profit$-4.0M$-5.0M$-5.0M$-8.0M$-10.0M
Net Profit$-4.0M$-4.0M$-6.0M$-14.0M$-14.0M
EPS$-0.25$-0.20$-0.28$-0.59$-0.57
Op Margin———-1502.3%-12454.2%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$5.0M$1.0M$35.0M$22.0M$15.0M
Total Liabilities$3.0M$3.0M$27.0M$22.0M$26.0M
Cash$4.0M$0$32.0M$18.0M$10.0M
Borrowings$0$0$25.0M$19.0M$20.0M

Latest News

Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights GlobeNewswire · Jul 14, 2026

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-4.0M$-3.0M$-6.0M$-7.0M$-8.0M
Investing Cash Flow$9.0M$0$-2.0M$-2.0M$-1.0M
Financing Cash Flow$0$0$-2.0M$3.0M$-1.0M
Net Cash Flow$3.0M$-4.0M$32.0M$-14.0M$-8.0M
Free Cash Flow$-4.0M$-4.0M$-7.0M$-7.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.36
FCF Yield-222825.23%
Quick Ratio0.53
Interest Coverage-1.50
Return 1Y-50.00%
Return 3Y-99.99%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Federation Des Caisses Desjardins Du Quebec1,9502024-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AIMD $1.49 -3.87% -0.43 $10.97M 0.00%
BMRA $1.61 +1.26% -1.09 $4.98M 0.00%
FEED $0.36 -6.34% -0.05 $393682 0.00%
IVF $0.96 -4.09% -0.01 $1.71M 0.00%
NDRA $4.33 -2.70% -0.54 $3.26M 0.00%

About Nemaura Medical Inc.

Nemaura Medical Inc. is a medical technology company dedicated to inventing, developing, and bringing to market diagnostic medical devices. Its flagship product, sugarBEAT, is an innovative, non-invasive continuous glucose monitoring (CGM) system. This device is designed to assist individuals with Type 1 and Type 2 diabetes in managing their condition, and it can also screen for pre-diabetic states. Beyond this, Nemaura offers proBEAT, a wellness guidance service that delivers educational prompts to users about factors influencing their blood sugar profiles. The company also conducts specialized programs aimed at diabetes prevention and reversal. Established in 2009, Nemaura Medical Inc. operates from its headquarters in New York City.

Nemaura Medical Inc. (NMRD) stock trades at $0.00 with a market capitalization of $4035. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.05. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Nemaura Medical Inc. generates a return on equity (ROE) of 116.67% — well above the market average, a sign of a high-quality business, return on capital employed of 124.54%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: nemauramedical.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides